Skip to main content

Thornal Kevin R's Form 4 filing

Hologic Inc (HOLX) · filed Nov 17, 2022

Accession no.
0001127602-22-025948
Filed
Nov 17, 2022
Trade date
Nov 15, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.44M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Thornal Kevin RCIK 0001783992Officer (Group Pres, Global Diagnostics)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 15, 2022Common StockSSaleDisposed−6,628$75.37−$499,552.3662,368Direct
Nov 15, 2022Common StockMOption exerciseAcquired+12,490$40.85+$510,216.574,858Direct
Nov 15, 2022Common StockSSaleDisposed−12,490$75.30−$940,49762,368Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Nov 15, 2022Common StockMOption exerciseDisposed−12,490$0.00$00Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)